Navigation Links
Fulgent Therapeutics Announces That CAP (College of American Pathologists) Has Accredited Their Clinical Laboratory
Date:10/24/2013

Temple City, CA (PRWEB) October 24, 2013

Fulgent Therapeutics, a CLIA Certified Laboratory, is proud to announce accreditation by the College of American Pathologists (CAP). CAP’s Laboratory Accreditation Program is recognized by the United States government as being equal-to or more-stringent-than the government’s own inspection program. With this accreditation, Fulgent's Diagnostic Lab is a part of an internationally recognized group of facilities that meet the highest standards of excellence and best practices in laboratory operations.    

The CAP accreditation process was comprised of CAP inspectors that examined Fulgent’s laboratory procedure, quality control, safety program, staff qualifications, equipment, facilities, and overall management and laboratory records.

Fulgent Therapeutics has recently announced a wide range of diagnostic panels for a variety of inherited diseases, including cardiology, pediatrics, and neurology as well as inherited cancer predisposition.

Additional information: info(at)fulgent-therapeutics(dot)com or 626-350-0537 x106.

About Fulgent Therapeutics LLC: Fulgent’s diagnostic lab was CLIA approved in May 2012. Fulgent Diagnostics provides affordable next generation genetic tests using massively parallel processes to a global community. Tests range from hereditary cancers to esoteric diseases. For a complete list of tests available please visit: fulgent-therapeutics.com/testing.    

About the College of American Pathologists:

The College of American Pathologists (CAP) is a medical society that serves more than 18,000 physician members and the global laboratory community. It is the world’s largest association composed exclusively of board-certified pathologists and is the worldwide leader in laboratory quality assurance. The College advocates accountable, high-quality, and cost-effective patient care. More information about the CAP can be found at http://www.cap.org.

Fulgent Therapeutics LLC
4978 Santa Anita Ave, Ste. 205
Temple City, CA
91780

Read the full story at http://www.prweb.com/releases/2013/10/prweb11264218.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Fulgent Therapeutics Announces Their Comprehensive Hereditary Cancer Test Including BRCA1 and BRCA2 Analysis
2. Multiple Myeloma Therapeutics Future Discussed in In-demand MP Advisors Report Published at MarketPublishers.com
3. American Assoc. for Cancer Research co-hosts conference on molecular targets and cancer therapeutics
4. Global Dermatophytic Onychomycosis Therapeutics Market 2012 - 2016: Worldwide Industry Latest Market Share, Growth, Size, Trends, Strategy And Forecast Research Report
5. Global Huntington’s Disease Therapeutics Industry
6. Obesity Therapeutics to 2019 - Safety Concerns Hinder Drug Performance Despite Large Market Opportunity
7. Mount Sinai Grants Exclusive License to Plexcera Therapeutics to Develop Treatments for Farber Disease and Cystic Fibrosis
8. Multiple Sclerosis Therapeutics Market to 2019 – Treatment Diversification and Pipeline Innovation to Drive Growth, Says a New Report at RnRMarketResearch.com
9. Refractory Hematological Malignancies (MDS, AML) Market Emerging Therapeutics Analysis Available at ReportsnReports.com
10. Pain Management Therapeutics Market Will Decline USD 29.47 Billion in 2018 : Transparency Market Research
11. Pain Management Therapeutics Market Will Decline USD 29.47 Billion in 2018 : Transparency Market Research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/24/2017)... ... , ... Texas Physical Therapy Specialists (TexPTS) is pleased to announce the ... clinic is the group’s 7th location in San Antonio and 23rd in Texas. ... care from the clinic, which opened March 22, 2017. , The team ...
(Date:3/24/2017)... (PRWEB) , ... March 24, 2017 , ... ... financial planning, and related services to families and business owners across eastern Michigan, ... at feeding regional families struggling with financial difficulties. , The Oxford/Orion FISH Food ...
(Date:3/24/2017)... Diego, Calif. (PRWEB) , ... March 24, 2017 ... ... has raised over $100,000 for its innovative EcoQube Frame vertical micro-veggies garden on ... the instant demand for the product – with nearly 2,000 consumers (and counting) ...
(Date:3/24/2017)... (PRWEB) , ... March 24, 2017 , ... ... Assili, announce that they are now offering treatments for sleep apnea and TMJ ... dental offices. Sleep apnea , specifically the obstructive type, is increasingly being ...
(Date:3/24/2017)... ... March 24, 2017 , ... The law firm of ... N.Y., is pleased to announce Westchester resident Lauren C. Enea has joined the firm ... the firm, will concentrate her practice in elder law, Medicaid planning and applications, and ...
Breaking Medicine News(10 mins):
(Date:3/24/2017)... 2017 Today Stock-Callers.com have issued research ... Neovasc Inc. (NASDAQ: NVCN), Hologic Inc. (NASDAQ: HOLX), Edwards Lifesciences ... SSH ). These companies are part of the Healthcare sector, ... March 23 rd , 2017, with the NYSE Health Care ... care companies in the S&P 500 were down about 0.4% ...
(Date:3/24/2017)... INDIANAPOLIS , March 24, 2017  Eli ... today announced plans to invest $850 million in ... span facilities across its U.S. enterprise, including research ... The investments are being driven by demand for ... of potential medicines in development targeting cancer, pain, ...
(Date:3/24/2017)... March 23, 2017  Provectus Biopharmaceuticals, Inc. (OTCQB: ... a clinical-stage oncology and dermatology biopharmaceutical company, today ... Commitment Term Sheet (the "Definitive Financing") it entered ... the Company,s stockholders, who are referred to in ... Form 8-K filed with the Securities and Exchange ...
Breaking Medicine Technology: